Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis. - Datta I; Zahoor I; Ata N; Rashid F; Cerghet M; Rattan R; Poisson LM; Giri S (Metabolites, 2024)